<i>Leishmania</i> Animal Models Used in Drug Discovery: A Systematic Review
Many different animal models are in use for drug development for leishmaniasis, but a universal model does not exist. There is a plethora of models, and this review assesses their design, quality, and limitations, including the attention paid to animal welfare in the study design and execution. A sy...
Main Authors: | Jacob van der Ende, Henk D. F. H. Schallig |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/13/10/1650 |
Similar Items
-
<i>In Vitro</i> Drug Susceptibility of a <i>Leishmania (Leishmania) infantum</i> Isolate from a Visceral Leishmaniasis Pediatric Patient after Multiple Relapses
by: Bianca A. Ferreira, et al.
Published: (2023-07-01) -
Antileishmanial Drug Discovery and Development: Time to Reset the Model?
by: Ana Isabel Olías-Molero, et al.
Published: (2021-12-01) -
Comparative Draft Genomes of <i>Leishmania orientalis</i> Isolate PCM2 (Formerly Named <i>Leishmania siamensis</i>) and <i>Leishmania martiniquensis</i> Isolate PCM3 from the Southern Province of Thailand
by: Pornchai Anuntasomboon, et al.
Published: (2022-03-01) -
Systematic in silico Evaluation of Leishmania spp. Proteomes for Drug Discovery
by: Crhisllane Rafaele dos Santos Vasconcelos, et al.
Published: (2021-04-01) -
Drug Discovery for Cutaneous Leishmaniasis: A Review of Developments in the Past 15 Years
by: Hannah N. Corman, et al.
Published: (2023-11-01)